Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Steven Feldman MD, PhD

Steven R. Feldman MD, PhD

Professor of Dermatology, Pathology & Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Dr. Steve Feldman is Professor of Dermatology, Pathology & Public Health Sciences at the Wake Forest University School of Medicine. His research studies into patients’ adherence to topical treatments are transforming how physicians understand and manipulate patients’ use of treatment for chronic skin diseases. Dr. Feldman was the founder of www.DrScore.com, an online doctor rating/patient feedback website, and he is chief technology officer for Causa Research, a company that provides adherence improving services to industry. Feldman has authored over 600 peer reviewed medical articles. Dr. Feldman is a regular columnist for PM360 on adherence and author of the books Compartments and Practical Ways to Improve Patients’ Treatment Outcomes.

Disclosures

Dr. Steven Feldman has received research, speaking and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment.

Recent Contributions to PracticeUpdate:

  1. Prevalence and Clinical Impact of Topical Corticosteroid Phobia Among Patients With Chronic Hand Eczema
  2. Assessing the Landscape of Supervision and Complication-Reporting in Medical Spas
  3. Re-Evaluating the Role of Malassezia in Seborrheic Dermatitis
  4. Drug Survival of Biologic Therapies Among Patients With Palmoplantar Pustulosis
  5. Outcomes of Tildrakizumab Induction Therapy Followed by As-Needed Dosing in Patients With Mild to Moderate Psoriasis
  6. Guselkumab Induction Therapy Has Long-Lasting Efficacy in Patients With Mild Psoriasis
  7. Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in Patients With Non-Melanoma Skin Cancer
  8. Efficacy and Risk Stratification of JAK Inhibitors for Moderate to Severe Atopic Dermatitis
  9. Trajectories and Prognosis After Discontinuation of Biologics Owing to Remission in Patients With Psoriasis
  10. Clinical Characteristics and Risk of Psoriatic Arthritis in Patients With Isolated Nail Psoriasis

Most Read This Week

Recently Updated